Increased neurofilament light chain plasma levels as a biological marker of mild cognitive impairment in Parkinson’s disease
Objective: To examine whether PD-MCI patients have increased plasma neurofilament light chain (NfL) levels compared to PD with normal cognition (PD-NC) and healthy controls (HC).…The relationship between neuromelanin-sensitive MRI, [123I] meta-iodobenzylguanidine scintigraphy and cognition, in patients with Parkinson’s disease
Objective: We investigate the relationship between the contrast ratio of locus coeruleus (LC-CR) in neuromelanin-sensitive MRI(NMI), MIBG scintigraphy, and cognition/hallucination, in patients with Parkinson’s disease.…Pattern of cerebral perfusion in early de novo Parkinson’s disease with mild cognitive impairment using voxel-based analysis of 3D arterial spin-labeling imaging
Objective: We aimed to investigate the patterns of cerebral perfusion in early de novo Parkinson’s disease (PD) patients with different cognitive states and to determine…Sex-associated difference in the presentation and progression of Parkinson’s disease
Objective: Identifying the contribution of sex to the heterogeneity in presentation and progression of Parkinson’s disease (PD). Background: The different prevalence of Parkinson’s disease (PD)…Brain activity underpinning visual cues for gait impairment in Parkinson’s disease
Objective: To examine brain activity when walking with and without visual cues in Parkinson’s disease (PD). Background: Gait impairments and Freezing of Gait (FOG) in…Predictors of the progression of dementia with Lewy bodies
Objective: To define predictors of the progression of dementia with Lewy bodies (DLB). Background: Dementia with Lewy bodies is a progressive disabling neurodegenerative disease with…Progression of cortical thinning and neuropsychological decline in isolated Rapid Eye Movement sleep behavior disorder
Objective: We aimed to investigate the progression over time of cortical thickness and cognitive functions in isolated REM-sleep behaviour disorder (IRBD) compared to healthy controls (HC).…Can clinical outputs predict BDNF levels in people with Parkinson’s disease?
Objective: To modelling the relationship between Brain-Derived Neurotrophic Factor (BDNF) levels and clinical variables (stages of disease and cognition) in people with Parkinson's disease (PD).…Object and action naming test in cognitive subtypes in nondemented patients with Parkinson´s disease
Objective: The aim of our study was to identify more homogenous profiles of patients with Parkinson´s disease (PD) without cognitive decline and to compare language…Clinical outcomes after DBS surgery in cognitively impaired patients with PD
Objective: To describe clinical outcomes after DBS in patients with PD and moderate cognitive impairment (CI). Background: DBS is generally contraindicated in PD patients with…
- « Previous Page
- 1
- …
- 43
- 44
- 45
- 46
- 47
- …
- 117
- Next Page »